Registered dietitian Ayla Barmmer told The Post that about 15% of her patients taking GLP-1 medications have struggled to ...

The global interest in medical weight loss solutions has surged, driven by the success stories and clinical efficacy of medications like Ozempic and Wegovy. Originally developed for managing Type 2 ...

After experiencing high growth in the U.S. telehealth scene, Hims is taking its personalized obesity treatments ...

Rising teen obesity prompts a surge in Novo Nordisk's Wegovy usage among adolescents, with prescriptions climbing 50% in 2024 ...

A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...

Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...

Hims did not provide financial terms of the deal, but a company spokesperson said these details will be shared with its ...

The FDA launched a generative artificial intelligence tool designed to help employees, such as scientific reviewers and ...

More and more people in the UK are using Ozempic and Wegovy, according to NHS data. The drug has the potential to cause ...

The FDA rolled out a generative AI tool for speeding regulatory reviews, announcing its launch nearly a month ahead of a June ...